» Articles » PMID: 14722019

Comparison of Acute and Chronic Antioxidant Interventions in Experimental Renovascular Disease

Overview
Specialties Nephrology
Physiology
Date 2004 Jan 15
PMID 14722019
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) can modulate renal hemodynamics and function both directly, by leading to vasoconstriction, and indirectly, by inducing renal inflammation and tissue growth. The involvement of oxidative stress in the pathogenesis of renovascular disease (RVD) is increasingly recognized, but the relative contribution of long-term tissue injury to renal dysfunction remains unclear. We hypothesized that functional and structural alterations elicited by oxidative stress in RVD would be more effectively modulated by chronic than by acute antioxidant intervention. Renal hemodynamics and function were quantified in vivo in pigs using electron-beam computed tomography at baseline and after vasoactive challenge (ACh and sodium nitroprusside); after 12 wk of RVD (simulated by concurrent hypercholesterolemia and renal artery stenosis, n = 7); RVD acutely infused with the SOD-mimetic tempol (RVD+tempol, n = 7); RVD chronically supplemented with antioxidant vitamins C (1 g) and E (100 IU/kg; RVD+vitamins, n = 7); or control (normal, n = 7). Renal tissue was studied ex vivo using immunoblotting and immunohistochemistry. Basal renal blood flow (RBF) and glomerular filtration rate were similarly decreased in all RVD groups. ACh-stimulated RBF remained unchanged in RVD, increased in RVD+tempol, but further increased (similarly to normal) in RVD+vitamins (P < 0.05 vs. RVD). Furthermore, RVD+vitamins also showed a decreased presence of superoxide anion, decreased NAD(P)H-oxidase and nitrotyrosine expression, increased endothelial nitric oxide synthase expression, and attenuated renal fibrosis. Chronic antioxidant intervention in early RVD improved renal hemodynamic responses more effectively than acute intervention, likely due to increased nitric oxide bioavailability and decreased structural injury. These suggest that chronic tissue changes play an important role in renal compromise mediated by oxidative stress in RVD.

Citing Articles

Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.

Eirin A, Chade A, Lerman L Hypertension. 2023; 81(2):206-217.

PMID: 37869904 PMC: 10842320. DOI: 10.1161/HYPERTENSIONAHA.123.21362.


Adjunctive mesenchymal stem/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy.

Chen X, Zhang X, Jiang K, Krier J, Zhu X, Conley S J Cell Physiol. 2020; 235(12):9806-9818.

PMID: 32430932 PMC: 7529809. DOI: 10.1002/jcp.29794.


A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease.

Williams E, Chade A Sci Rep. 2020; 10(1):440.

PMID: 31949240 PMC: 6965143. DOI: 10.1038/s41598-019-57386-8.


Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.

Saad A, Herrmann S, Eirin A, Ferguson C, Glockner J, Bjarnason H Circ Cardiovasc Interv. 2017; 10(9).

PMID: 28916603 PMC: 5659347. DOI: 10.1161/CIRCINTERVENTIONS.117.005487.


Renal auto-transplantation promotes cortical microvascular network remodeling in a preclinical porcine model.

Maiga S, Allain G, Hauet T, Roumy J, Baulier E, Scepi M PLoS One. 2017; 12(7):e0181067.

PMID: 28704481 PMC: 5509304. DOI: 10.1371/journal.pone.0181067.